- Home
- LGCB vs CRIS Comparison
LGCB vs CRIS Comparison
Compare LGCB & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LGCB | CRIS |
|---|---|---|
| Founded | 2011 | 2000 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.7M | 14.0M |
| IPO Year | 2023 | 2000 |
Fundamental Metrics
Financial Performance| Metric | LGCB | CRIS |
|---|---|---|
| Price | $0.55 | $0.59 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 127.9K | ★ 731.4K |
| Earning Date | 01-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,898,000.00 |
| Revenue This Year | N/A | $27.10 |
| Revenue Next Year | N/A | $67.74 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $0.43 | $0.49 |
| 52 Week High | $3.10 | $3.13 |
Technical Indicators
Market Signals| Indicator | LGCB | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 17.73 | 43.66 |
| Support Level | N/A | $0.49 |
| Resistance Level | $2.23 | $0.79 |
| Average True Range (ATR) | 0.12 | 0.07 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 11.85 | 23.08 |
Price Performance
Historical ComparisonAbout LGCB Linkage Global Inc
Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.